Daniel Stover

Assistant Professor

The Ohio State University Comprehensive Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Daniel Stover is an Assistant Professor at the Ohio State University Comprehensive Cancer Center in the United States. His research focuses on breast cancer, particularly in areas such as the impact of uncertainty on cognitive function among patients, the role of small G proteins in triple negative breast cancer, and the efficacy of various treatments for metastatic breast cancer. Dr. Stover has contributed significantly through his recent publications, exploring topics ranging from immune biomarkers to the effects of COVID-19 on cancer patients.

Articles (12)

Year:

2025

Year:

2024

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (8)

Christopher McNair

Thomas Jefferson University

UNITED STATES

View details

Steffen Lindert

Ohio State University

UNITED STATES

View details

wenrui duan

PI/ Associate Professor

Florida International University

UNITED STATES

View details

Zaibo Li

UNITED STATES

View details

Yesol Yang

Assistant professor

Ohio State University

UNITED STATES

View details

Robert Wesolowski

Assistant Professor

Ohio State University

UNITED STATES

View details

Maryam Farvid

Associate Professor

George Mason University

UNITED STATES

View details

Andrea Zimmer

Assistant Professor

University of Nebraska Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daniel Stover

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Effect of Intolerance of Uncertainty on Perceived Cognitive Function Among Breast Cancer Patients Before Chemotherapy

The RAL Small G Proteins Are Clinically Relevant Targets in Triple Negative Breast Cancer

Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study.

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer.

Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study.

Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experience.

Computational cancer cell models to guide precision breast cancer medicine

Erythrocyte membrane fatty acids and breast cancer risk by tumor tissue expression of immuno-inflammatory markers and fatty acid synthase: a nested case-control study

Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer

Metastatic breast cancer patient perceptions of somatic tumor genomic testing

Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial

Collaborators (8)

Christopher McNair

Steffen Lindert

wenrui duan

Zaibo Li

Yesol Yang

Robert Wesolowski

Maryam Farvid

Andrea Zimmer

Make your next move.